PapersFlow Research Brief
Research on Leishmaniasis Studies
Research Guide
What is Research on Leishmaniasis Studies?
Research on Leishmaniasis Studies encompasses scientific investigations into the epidemiology, diagnosis, treatment, parasite biology, immunity, drug resistance, sandfly vectors, vaccine development, and societal impacts of leishmaniasis, a protozoan disease transmitted by sandflies.
The field includes 91,736 published works addressing global incidence, control strategies, and challenges in leishmaniasis management. "Leishmaniasis Worldwide and Global Estimates of Its Incidence" by Alvar et al. (2012) provided empirical data from national experts and literature reviews to update WHO estimates on case numbers and treatment practices. "Leishmaniasis: current situation and new perspectives" by Desjeux (2004) examined ongoing epidemiological patterns and potential advances in disease control.
Topic Hierarchy
Research Sub-Topics
Leishmaniasis Vaccine Development
This sub-topic covers antigen selection, adjuvant formulations, and clinical trials for leishmaniasis vaccines. Researchers evaluate efficacy in animal models and human phases.
Drug Resistance in Leishmania Parasites
This sub-topic investigates mechanisms of resistance to antimonials, miltefosine, and amphotericin B in clinical isolates. Researchers perform genomic sequencing and pharmacological assays.
Sandfly Vector Biology and Control
This sub-topic studies Phlebotomus and Lutzomyia sandfly ecology, behavior, and insecticide interventions. Researchers develop monitoring tools and transmission models.
Leishmaniasis Host Immunity Mechanisms
This sub-topic elucidates Th1/Th2 responses, macrophage activation, and cytokine networks in Leishmania infections. Researchers use knockout models and immunophenotyping.
Leishmaniasis Epidemiology and Global Burden
This sub-topic maps incidence, risk factors, and socioeconomic impacts across endemic regions. Researchers integrate GIS and surveillance data for forecasting.
Why It Matters
Leishmaniasis research supports public health efforts by informing global incidence estimates and control measures, as detailed in "Leishmaniasis Worldwide and Global Estimates of Its Incidence" by Alvar et al. (2012), which compiled case data from over 80 countries to reveal 0.9–1.7 million new cases annually and guide WHO policy. Studies like "Leishmaniasis: current situation and new perspectives" by Desjeux (2004) highlight diagnostic and therapeutic gaps in endemic regions, enabling targeted interventions that reduce morbidity in affected populations, particularly in tropical and subtropical areas where the disease causes significant economic and health burdens.
Reading Guide
Where to Start
"Leishmaniasis Worldwide and Global Estimates of Its Incidence" by Alvar et al. (2012) serves as the starting point because it offers foundational data on global burden and WHO-coordinated incidence estimates, providing context for all subsequent studies.
Key Papers Explained
"Leishmaniasis Worldwide and Global Estimates of Its Incidence" by Alvar et al. (2012) establishes baseline epidemiology with case data from experts, which Desjeux (2004) in "Leishmaniasis: current situation and new perspectives" builds upon by analyzing persistent challenges and control perspectives. These connect through shared focus on incidence trends and management gaps, informing vector and treatment research.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent efforts emphasize drug resistance monitoring and vaccine trials, extending Alvar et al. (2012) incidence data into predictive modeling for high-burden regions, though no preprints from the last six months are available.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Leishmaniasis Worldwide and Global Estimates of Its Incidence | 2012 | PLoS ONE | 5.1K | ✓ |
| 2 | Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors | 2020 | Nature | 4.4K | ✓ |
| 3 | ACETYLORNITHINASE OF ESCHERICHIA COLI: PARTIAL PURIFICATION AN... | 1956 | Journal of Biological ... | 4.0K | ✓ |
| 4 | Synchronization of Plasmodium falciparum Erythrocytic Stages i... | 1979 | Journal of Parasitology | 3.7K | ✓ |
| 5 | TRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and Function | 1997 | Annual Review of Immun... | 2.6K | ✕ |
| 6 | A simple device for quantitative stool thick-smear technique i... | 1973 | PubMed | 2.4K | ✕ |
| 7 | Schalm's veterinary hematology | 1987 | Food and Chemical Toxi... | 2.3K | ✕ |
| 8 | Leishmaniasis: current situation and new perspectives | 2004 | Comparative Immunology... | 2.3K | ✕ |
| 9 | Chagas disease | 2010 | The Lancet | 2.1K | ✕ |
| 10 | Targets for Cell Cycle Arrest by the Immunosuppressant Rapamyc... | 1991 | Science | 2.0K | ✕ |
Frequently Asked Questions
What are the global incidence estimates for leishmaniasis?
Alvar et al. (2012) in "Leishmaniasis Worldwide and Global Estimates of Its Incidence" reported 0.9–1.7 million new cases annually based on data from national experts across multiple countries. The study updated WHO evidence through case reports and literature reviews from the prior five years. These figures underscore visceral and cutaneous forms prevalent in 88 countries.
What challenges does current leishmaniasis research address?
Desjeux (2004) in "Leishmaniasis: current situation and new perspectives" identified gaps in treatment access, diagnosis accuracy, and vector control. Research covers drug resistance, vaccine development, and epidemiological surveillance in endemic areas. These efforts aim to improve management amid rising cases in conflict zones.
How is leishmaniasis epidemiology studied?
Papers like "Leishmaniasis Worldwide and Global Estimates of Its Incidence" by Alvar et al. (2012) use national case data and literature synthesis for incidence mapping. Studies track sandfly vectors, human cases, and environmental factors. This approach reveals hotspots in South America, Africa, and Asia.
What role does the WHO play in leishmaniasis studies?
The WHO Leishmaniasis Control Team contributed to "Leishmaniasis Worldwide and Global Estimates of Its Incidence" by Alvar et al. (2012), coordinating expert inputs for global estimates. Their efforts standardize reporting and promote integrated control. This collaboration drives policy on treatment and surveillance.
What topics dominate leishmaniasis research?
Key areas include treatment, diagnosis, parasite biology, immunity, drug resistance, sandflies, vaccine development, and epidemiology. The field totals 91,736 works focused on protozoan infections. These topics address clinical, vector, and public health dimensions.
Open Research Questions
- ? How can accurate global incidence be measured amid underreporting in remote endemic areas?
- ? What mechanisms drive emerging drug resistance in Leishmania parasites?
- ? Which sandfly vector control strategies effectively reduce transmission rates?
- ? How do immune responses vary across visceral and cutaneous leishmaniasis forms?
- ? What barriers prevent scalable vaccine development for human leishmaniasis?
Recent Trends
The field maintains 91,736 works with steady output, as no five-year growth rate is specified; foundational papers like Alvar et al. with 5055 citations and Desjeux (2004) with 2299 citations continue dominating citations, indicating sustained reliance on epidemiology amid absent recent preprints or news.
2012Research Research on Leishmaniasis Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Research on Leishmaniasis Studies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers